Article
Lithium carbonate in Amyotrophic Lateral Sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A; protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial.
2022-10-04
Abstract excerpt
<title>Abstract</title> <p>Background Given the large genetic heterogeneity in Amyotrophic Lateral Sclerosis (ALS), it seems likely that genetic subgroups may benefit differently from treatment. An exploratory meta-analysis identified that patients homozygous for the C-allele at SNP rs12608932, a single nucleotide polymorphism in the gene <italic>UNC13A</italic>, had a statistically significant survival benefit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fd700954-aa06-57e6-9fe2-3e7f1987bfc5
- DOI
- 10.21203/rs.3.rs-2125381/v1
